The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma

MYC is a major oncogenic driver of Multiple Myeloma (MM) and yet almost no therapeutic agents exist that target MYC in MM. Here we report that the let-7 biogenesis inhibitor LIN28B correlates with MYC expression in MM and is associated with adverse outcome. We also demonstrate that the LIN28B/let-7...

Descripción completa

Detalles Bibliográficos
Autores principales: Manier, Salomon, Powers, John T., Sacco, Antonio, Glavey, Siobhan V., Huynh, Daisy, Reagan, Michaela R., Salem, Karma Z., Moschetta, Michele, Shi, Jiantao, Mishima, Yuji, Roche-Lestienne, Catherine, Leleu, Xavier, Roccaro, Aldo M., Daley, George Q., Ghobrial, Irene M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382134/
https://www.ncbi.nlm.nih.gov/pubmed/27773931
http://dx.doi.org/10.1038/leu.2016.296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382134/
https://www.ncbi.nlm.nih.gov/pubmed/27773931
http://dx.doi.org/10.1038/leu.2016.296

Ejemplares similares